no.silva
TL2 · Medellín
Contributes reviews on supplier material. Based in Medellín.
Joined 8 May 2025 · last posted 11d
90 posts, newest first. Showing up to 150.
-
Follow-up: Reading an interaction checker output critically Replied, post #51 · Practice › Interactions · 17 Jul 2026 · 20 likes Picking up post #48: that is the part I would want checked first. Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body…
-
What is genuinely unknown about long-term amylin agonism Replied, post #45 · Compounds › Cagrilintide & amylin analogues · 16 Jul 2026 · 7 likes Building on post #43 rather than restating it. Research-use-only cagrilintide is not approved for human use and the published evidence base is a clinical-trial evidence…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #43 · Clinical › Comorbidities · 12 Jul 2026 · 4 likes This follows post #42 rather than contradicting it. Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral medications and…
-
[2026 update] Temperature indicator cards: worth asking for? Replied, post #18 · Sourcing › Logistics · 10 Jul 2026 · 33 likes Answering the question post #16 raises rather than the one it answers. Anyone deciding whether a delay is a problem should ask what would change if they waited another…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #46 · Compounds › Retatrutide · 8 Jul 2026 · 17 likes Triple agonism at GLP-1, GIP and glucagon receptors is the defining feature and the glucagon limb is the one people find counter-intuitive. It raises energy expenditure…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #27 · Practice › Side effects · 3 Jul 2026 · 1 like Post #26 is the version of this I will quote in future. One addition. Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect profile.…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #108 · Evidence › Journal club · 2 Jul 2026 · 23 likes The useful distinction on orforglipron phase 2 is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has…
-
Submitting a sample: the process end to end Replied, post #45 · Sourcing › Independent verification · 28 Jun 2026 · 10 likes Reading back through the submitting a sample threads from last year, the same three questions come up every time and only one of them has ever been answered properly.…
-
Sulfonylureas: the interaction most worth taking seriously — what changed since Replied, post #3 · Practice › Interactions · 23 Jun 2026 · 18 likes Gastrointestinal symptoms from one compound can mask or mimic an interaction with another. Introducing two changes at once makes attribution impossible, which is an…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #30 · Access › International · 22 Jun 2026 · 20 likes Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks.
-
Asking a follow-up: new topic or new reply? Replied, post #12 · Start Here › How to Ask · 15 Jun 2026 · 2 likes Adding the measurement that post #9 says would settle it. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #82 · Access › Insurance & coverage · 11 Jun 2026 · 2 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #119 · Practice › Storage & stability · 10 Jun 2026 · 0 likes Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know whether it has been sitting for weeks or days, the…
-
Prescription requirements and telehealth models — a second dataset Replied, post #56 · Sourcing › Regulatory · 7 Jun 2026 · 0 likes The arithmetic in post #54 is right; the assumption feeding it is the part to check. If you can confirm or contradict a position for your own region, please date the…
-
Tracking intake honestly when appetite is absent Replied, post #50 · Nutrition & Training › Protein & intake · 6 Jun 2026 · 0 likes Right, and stated more narrowly than I would have dared to state it.
-
Hair shedding at month three: mechanism and time course — the long version Replied, post #20 · Practice › Side effects · 1 Jun 2026 · 0 likes One caution on Hair shedding: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely stated.
-
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #51 · Practice › Storage & stability · 31 May 2026 · 0 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. That is the version I would defend. It…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? Replied, post #20 · Sourcing › Independent verification · 30 May 2026 · 7 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
-
Recording a dissent on a document rather than suppressing it Replied, post #17 · Documentation › Doc review · 27 May 2026 · 25 likes Nothing in a maintained document is medical advice and the review should confirm the page says so where it matters rather than only in a footer.
-
Designing a personal experiment that could change your mind — one year on Replied, post #50 · Research Methods › N-of-1 designs · 23 May 2026 · 33 likes Post #49 answers the question as asked. The question underneath it is different. A washout period between conditions is what stops one bleeding into the next, and its…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #48 · Devices › Syringes & needles · 22 May 2026 · 29 likes 0.3 ml versus 0.5 ml is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
-
Coming back to: Time to steady state after a dose increase Replied, post #57 · Pharmacology › Pharmacokinetics · 20 May 2026 · 13 likes The time to maximum concentration after a subcutaneous dose in this class is measured in days rather than hours, which surprises people expecting an injection to act…
-
Follow-up: Sleep quality changes during weight loss Replied, post #19 · Wellbeing › Sleep · 9 May 2026 · 10 likes Obstructive sleep apnoea: pre-existing OSA can worsen with weight before it improves (apnoea-hypopnoea index goes up as soft tissue inflames before weight is lost).…
-
Official shortage notices and what they authorise Replied, post #3 · Access › Shortages · 10 Apr 2026 · 1 like Adding the measurement that the opening post says would settle it. Anyone reporting availability should say the region and the date, because both determine whether the…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #42 · Practice › Administration · 9 Apr 2026 · 18 likes I read post #39 twice before replying, because I had assumed the opposite. Drawing up with one needle and injecting with another: a reasonable practice if you have…
-
Spike-and-recover accuracy for a peptide assay Replied, post #8 · Analytics › Method validation · 6 Apr 2026 · 0 likes Reading back through the spike-and-recover accuracy threads from last year, the same three questions come up every time and only one of them has ever been answered…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #68 · Practice › Interactions · 30 Mar 2026 · 0 likes Taking anaesthesia and elective surgery seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled…
-
Choosing which test to pay for, given a fixed budget Replied, post #31 · Sourcing › Independent verification · 19 Mar 2026 · 16 likes Noted, and thank you for writing it out rather than summarising it.
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #80 · Regional › UK & Ireland · 17 Mar 2026 · 0 likes Taking post #77 at face value and following it one step further. Cross-border arrangements: some people source from other EU countries. Rules on import for personal use…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #46 · Compounds › Repair & healing peptides · 12 Mar 2026 · 5 likes Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in supplier marketing and poorly supported by…
-
Adsorption to container surfaces and to plastics Replied, post #16 · Pharmacology › Formulation chemistry · 7 Feb 2026 · 0 likes Checked the adsorption claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower scope.
-
Preprint servers and what screening they do Replied, post #40 · Evidence › Preprints · 30 Jan 2026 · 32 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
The headache that turns out to be dehydration Replied, post #153 · Nutrition & Training › Hydration & electrolytes · 24 Jan 2026 · 8 likes Coming back to post #149, because the follow-up matters more than the original answer. Commercial rehydration formulations are designed for a specific purpose and are…
-
Temperature loggers worth the money — the long version Replied, post #110 · Devices › Cold chain · 10 Jan 2026 · 0 likes A temperature indicator that has tripped tells you a threshold was crossed. It does not tell you for how long, and duration is most of what determines whether anything…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #80 · Practice › Interactions · 31 Dec 2025 · 32 likes Building on post #77 rather than restating it. Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries…
-
Prescription requirements and telehealth models Replied, post #71 · Sourcing › Regulatory · 16 Dec 2025 · 1 like Practical experience of prescription requirements and telehealth models, offered as one case with the conditions stated, not as a general finding. Conditions first,…
-
The decimal-point error, and the habit that catches it Replied, post #4 · Practice › Reconstitution · 13 Dec 2025 · 1 like The opening post is right about the mechanism and I think understates the practical bit. The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5…
-
Tracking a preprint to publication: a worked example Replied, post #108 · Evidence › Preprints · 11 Dec 2025 · 0 likes Everything in post #107 holds. The case it does not cover is the one I have. Check whether it was later published: searching for the preprint's first author and…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #30 · Pharmacology › Pharmacokinetics · 2 Dec 2025 · 0 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Pen dose counters: what a click does and does not guarantee Replied, post #26 · Devices › Pens & autoinjectors · 14 Nov 2025 · 2 likes The residual left in a cartridge at the end is deliberate overfill and is not a dose you are entitled to extract. Attempting to recover it is where accuracy goes. The…
-
Conference abstracts as evidence: the weakest common citation Started this topic · Evidence › Preprints · 25 Oct 2025 · 0 likes On the subject in the title: Conference abstracts as evidence: the weakest common citation Working notes rather than a conclusion. Reading an unrefereed manuscript…
-
What a purity-only report leaves out Replied, post #59 · Sourcing › Independent verification · 24 Oct 2025 · 0 likes Thank you — that answers what I came here to find out.
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #14 · Compounds › Tirzepatide · 19 Oct 2025 · 14 likes Reading rather than answering, but this is the post I would point somebody at.
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #54 · Analytics › COA interpretation · 18 Oct 2025 · 28 likes That matches what I have seen, for whatever a single anecdote is worth.
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #93 · Practice › Storage & stability · 12 Oct 2025 · 23 likes Adding what did not work for me on power cut for eleven hours, since the failures never get written up and they are half the useful information.
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #68 · Practice › Storage & stability · 4 Oct 2025 · 7 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed.
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #115 · Evidence › Preprints · 4 Oct 2025 · 25 likes A preprint with the data and code attached is frequently more checkable than a published paper without them. Reviewed and reproducible are different properties.
-
Hypertension improvement and when medication needs revisiting Replied, post #78 · Clinical › Comorbidities · 23 Sep 2025 · 5 likes Where I part company with post #75, and it is a narrow parting. Speaking only to hypertension improvement as I have actually seen it, rather than as it is usually…
-
Needle changes between doses on a reusable pen Replied, post #36 · Devices › Pens & autoinjectors · 18 Sep 2025 · 24 likes Reading rather than answering, but this is the post I would point somebody at.
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #109 · Access › Insurance & coverage · 6 Sep 2025 · 4 likes That is the distinction I keep failing to hold on to. Written down now.
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction — one… Replied, post #3 · marked as the solution · Compounds › Retatrutide · 4 Sep 2025 · 6 likes Glycaemic effects improved rather than worsened in the diabetes work despite the glucagon component, which is the observation that resolves the apparent paradox. It is…
-
Which panel is worth repeating and which is worth ignoring Replied, post #98 · Clinical › Bloodwork · 30 Aug 2025 · 0 likes The documentation on panel is better than this thread and I say that as someone who has posted in the thread.
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #32 · Pharmacology › Receptor biology · 27 Aug 2025 · 13 likes Ghrelin receptor agonism drives growth hormone release in pulses and also increases appetite, which is the effect people most reliably report and least often want.
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #78 · Compounds › Secretagogues & GH axis · 19 Aug 2025 · 26 likes A mass result for a short peptide is more discriminating than for a long one, because a single residue difference is a larger proportion of the total. That makes…
-
When a preprint is the best available evidence and we say so Replied, post #33 · Evidence › Preprints · 7 Aug 2025 · 0 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
-
Titles that describe the question, not the situation Replied, post #63 · Start Here › How to Ask · 3 Aug 2025 · 28 likes The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
-
Are there stupid questions here? A staff answer, at length Replied, post #21 · Start Here › Welcome · 29 Jul 2025 · 23 likes Good question, well framed, and I would like to see it answered properly.
-
Holding a dose indefinitely: is there a documented downside? Replied, post #32 · Practice › Dosing & titration · 27 Jul 2025 · 27 likes If someone has run holding a dose properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
-
Persistent vomiting and the threshold for seeking help Replied, post #6 · Safety › Adverse events · 15 Jul 2025 · 3 likes Marking my uncertainty on persistent vomiting explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it…
-
Coming back to: Official shortage notices and what they authorise Replied, post #54 · Access › Shortages · 11 Jul 2025 · 9 likes A shortage of one presentation is not a shortage of all of them, and the published notices are specific about which. I keep a log of this specifically because memory is…
-
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #15 · Compounds › Repair & healing peptides · 3 Jul 2025 · 0 likes Whatever the answer on BPC-157 turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the correction.
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #115 · Compounds › Tirzepatide · 20 Jun 2025 · 32 likes On post #111 — agreed on the reasoning, with one qualification. Two things can be true about tirzepatide in type 2 diabetes at once: the mechanism is plausible and the…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #43 · Compounds › Oral incretins · 6 Jun 2025 · 0 likes Picking up post #42: that is the part I would want checked first. Oral bioavailability is variable between people. Some people absorb well; others absorb poorly. That…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #102 · Sourcing › Red flags · 27 May 2025 · 0 likes Taking post #101 at face value and following it one step further. Nothing here should be read as an accusation against a named company, and the guidelines exist so that…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #124 · Evidence › Journal club · 26 May 2025 · 0 likes Post #120 describes the usual case. This is about the unusual one. The most useful thing anyone has posted about SURMOUNT-1 in this category was a table of what had…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #66 · Data & Tools › Calculators · 13 May 2025 · 1 like Maintaining a calculator means checking the arithmetic against hand-worked cases at each review, not checking that it still loads.
-
Follow-up: Documentation that appears only after payment Replied, post #30 · Sourcing › Red flags · 28 Apr 2025 · 0 likes On post #28 — agreed on the reasoning, with one qualification. Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #12 · Clinical › Comorbidities · 3 Apr 2025 · 2 likes A condition that affects nutrition or absorption changes the calculus around a treatment that reduces intake, and that interaction is mostly unstudied.
-
A page that has drifted out of date and needs a maintainer Replied, post #82 · Documentation › Wiki requests · 28 Mar 2025 · 19 likes Everything in post #80 holds. The case it does not cover is the one I have. Documents that are mostly a worked example age better than documents that are mostly a…
-
Second pass at: Cagrilintide's dosing interval and the pharmacokinetics behind it Started this topic · Compounds › Cagrilintide & amylin analogues · 3 Mar 2025 · 9 likes On the subject in the title: Second pass at: Cagrilintide's dosing interval and the pharmacokinetics behind it Working notes rather than a conclusion. A comparison…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #41 · Analytics › COA interpretation · 2 Mar 2025 · 0 likes Building on post #38 rather than restating it. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to…
-
Revisiting: Aggregate verification data across the directory, with caveats Replied, post #9 · Sourcing › Independent verification · 15 Feb 2025 · 6 likes I had written a reply contradicting post #7 and deleted it. Here is what survived. Verification records are dated because they expire in usefulness. A result from two…
-
Distinguishing a deletion sequence by mass alone Replied, post #81 · Analytics › Mass spectrometry · 13 Feb 2025 · 0 likes On post #79 — agreed on the reasoning, with one qualification. Summarising the distinguishing a deletion sequence thread so far, since it is long and the answer is…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #13 · Documentation › Doc review · 6 Feb 2025 · 1 like Taking draft on reconstitution arithmetic seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled…
-
Gallbladder disease risk with rapid weight loss Replied, post #62 · Clinical › Comorbidities · 25 Jan 2025 · 10 likes Post #60 and I disagree about the size of the effect, not about the direction. Asking about a population rather than about yourself is a legitimate framing and…
-
[2026 update] New subcategory: rationale and scope Replied, post #154 · Meta › Announcements · 16 Jan 2025 · 31 likes Thank you for announcing it in advance rather than after. The number of places that do the reverse is remarkable.
-
Follow-up: Individual participant data versus aggregate data Replied, post #105 · Evidence › Meta-analyses · 12 Jan 2025 · 0 likes What I would tell a new member reading about Individual participant data versus aggregate for the first time: the confident posts are not the reliable ones, and the…
-
Building a sensible monitoring schedule with your prescriber Replied, post #32 · Clinical › Bloodwork · 19 Dec 2024 · 18 likes I had written a reply contradicting post #28 and deleted it. Here is what survived. Repeat before acting is standard practice for an isolated abnormal result on most…
-
Two sessions a week versus four: what the evidence supports Replied, post #22 · Nutrition & Training › Resistance training · 3 Dec 2024 · 0 likes I read post #18 twice before replying, because I had assumed the opposite. Reduced appetite makes fuelling a session harder, and that is a practical problem with…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #126 · Analytics › COA interpretation · 22 Nov 2024 · 2 likes A certificate is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is not nothing.
-
[2026 update] New subcategory: rationale and scope Replied, post #11 · Meta › Announcements · 18 Nov 2024 · 0 likes RSS: if you prefer to receive announcements by feed rather than visiting the site, RSS is available for this subcategory. I would be glad to be shown a cleaner way of…
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #2 · Evidence › Journal club · 10 Nov 2024 · 10 likes The opening post is right about the mechanism and I think understates the practical bit. The confident answers on SUSTAIN 6 and the well-sourced answers are not the…
-
Time to steady state after a dose increase Replied, post #162 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 31 likes Metabolism for peptide drugs is proteolytic rather than hepatic in the usual sense, which is why the cytochrome interaction questions that dominate small-molecule…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #21 · Sourcing › Regulatory · 4 Nov 2024 · 19 likes Narrowing post #18, because the general version has more than one answer. A label change is a regulatory event with a date and a document. Citing the document is what…
-
Requesting a page: what makes a good request — what changed since Replied, post #138 · Documentation › Wiki requests · 13 Oct 2024 · 0 likes Post #136 put the caveat in the right place and I want to underline it. A page that would need to be rewritten every quarter is usually better as a topic with a good…
-
Merging two pages that cover the same ground — the long version Replied, post #7 · Documentation › Wiki requests · 9 Oct 2024 · 3 likes The most useful requests here identify a specific confusion that keeps recurring rather than a subject that seems important.
-
Revisiting: A fridge failure and how I assessed the contents afterwards Replied, post #3 · Devices › Cold chain · 26 Sep 2024 · 1 like Regional stock shortens the exposure window more effectively than any packing improvement, which is the practical argument for it beyond speed. Reading it back, the…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #46 · Clinical › Bloodwork · 21 Sep 2024 · 11 likes Thank you for taking the time. That was more work than a reply usually is.
-
Correlation in a self-tracked dataset: what it can support Replied, post #35 · Research Methods › Statistics · 21 Aug 2024 · 10 likes A p-value is the probability of data at least this extreme given the null hypothesis. It is not the probability the hypothesis is false, and almost every plain-language…
-
Blind submission and why it changes minds Replied, post #4 · Sourcing › Independent verification · 24 Jun 2024 · 23 likes This follows post #3 rather than contradicting it. It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything other than…